Bruker BioSciences Corporation Files Definitive Proxy with the SEC, Including Proposals for Acquisition of Bruker Optics.BILLERICA, Mass. -- Bruker BioSciences Corporation Bruker Biosciences Corporation is a Massachusetts-based company formed in 2003 which develops and manufactures scientific instrumentation for academic research and industrial use. (Nasdaq: BRKR BRKR Breaker ) announced today that it has filed a definitive proxy statement Proxy Statement A document containing the information that a company is required by the SEC to provide to shareholders so they can make informed decisions about matters that will be brought up at an annual stockholder meeting. with the Securities and Exchange Commission for its annual meeting of shareholders, which includes proposals relating to shareholder approval of its proposed acquisition of Bruker Optics Inc. ABOUT BRUKER BIOSCIENCES (NASDAQ: BRKR) Bruker BioSciences Corporation, headquartered in Billerica, Massachusetts, is the publicly traded parent company of Bruker AXS Inc. and Bruker Daltonics Inc. Bruker AXS is a leading developer and provider of life science, materials research, and industrial X-ray analysis tools. Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry mass spectrometry or mass spectroscopy Analytic technique by which chemical substances are identified by sorting gaseous ions by mass using electric and magnetic fields. . For more information, please visit www.bruker-biosciences.com |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion